Pluri Inc - Wutah pendapatan triwulanan PLUR

Pluri (PLUR) - logo korporat

Current losses and the strategic shift at Pluri Inc. (PLUR) are already priced in. The percentage growth in quarterly sales allows for an assessment of the business's fundamental stability, where the 140.80 mark serves as a relevant indicator. Future prospects depend on the validation of the PLX 3D platform and clinical data. Market capitalization relies on biopharmaceuticals and cultivated meat, promising returns through royalties from innovative health products.

PLUR Tingkat wutah dodolan sajrone kuartal Pluri Inc. (28.04.2023 - 20.11.2026)

Rincian metrik komprehensif lan analitis Pluri Inc. (PLUR)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental perusahaan:Pluri - PLUR
Produk seri Pluri Inc

The commercial revenue dynamics of Pluri Inc. confirm the resilience of a business model strengthened by the implementation of zero-waste biotechnologies and the optimization of water consumption during drug synthesis. By analyzing the quarterly revenue growth rate, an investor can observe the percentage change in income over three months, allowing for a mathematical refinement of the asset's risk profile and volatility via Sharpe and Sortino ratios, rather than relying blindly on past successes.

Pesaing Pluri Inc. (PLUR)

ASND - Wutah pendapatan kuartal marang kuartal|MDGL: Wutah pendapatan kuartal marang kuartal|CORT: Wutah pendapatan triwulanan|RYTM - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Akero Corp|Metsera Therapeutics (MTSR) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal moonlaketx.com (MLTX)|Wutah dodolan triwulanan Crinetics Pharmaceuticals CRNX|Wutah pendapatan kuartal marang kuartal NewAmsterdam Pharma N.V. NAMS|Tingkat wutah dodolan sajrone kuartal Soleno Therapeutics Inc (SLNO)|FOLD - Wutah pendapatan kuartal marang kuartal|ETNB: Wutah pendapatan kuartal marang kuartal|AGIO: Wutah pendapatan triwulanan|Structure Therapeutics Inc. - Tambahing pendapatan triwulanan|MDXG (MiMedx Corp) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Rezolute Inc RZLT|Wutah pendapatan triwulanan LXRX|Tingkat wutah dodolan sajrone kuartal MBX Corp|Altimmune Pharma - Wutah dodolan triwulanan|Wutah pendapatan triwulanan aardvarktherapeutics.com AARD|SGMT: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan BIOA (BioAge Labs)|BMEA: Wutah pendapatan triwulanan|QNCX: Owah-owahan dodolan kuartal marang kuartal|GUTS (Fractyl Health, Inc.) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan vtvtherapeutics.com|Wutah dodolan triwulanan ATPC (Agape ATP Corp)|Tingkat wutah dodolan sajrone kuartal Synlogic Inc.|Wutah pendapatan kuartal marang kuartal Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Tingkat wutah pendapatan sajrone kuartal|Spruce Biosciences Inc. - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Wutah pendapatan kuartal marang kuartal|Lumos Pharma - Tambahing pendapatan triwulanan|ONVO (Organovo Corp) - Wutah pendapatan triwulanan|Radius Pharmaceuticals (RDUS) - Tingkat wutah dodolan sajrone kuartal